These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 35666390)

  • 1. Liver cancer and hepatic decompensation events in patients hospitalized with viral hepatitis in Spain.
    Ramos-Rincon JM; Pinargote-Celorio H; de Mendoza C; Ramos-Belinchón C; Barreiro P; Treviño A; Corral O; Soriano V
    Hepatol Int; 2022 Oct; 16(5):1161-1169. PubMed ID: 35666390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain.
    Ramos-Rincon JM; Pinargote-Celorio H; de Mendoza C; Ramos-Belinchón C; Barreiro P; Treviño A; Corral O; Soriano V
    Aliment Pharmacol Ther; 2023 Mar; 57(5):540-548. PubMed ID: 36320189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C hospitalizations in Spain and impact of new curative antiviral therapies.
    Ramos-Rincon JM; Pinargote-Celorio H; de Mendoza C; Ramos-Belinchón C; Barreiro P; Gómez-Gallego F; Corral O; Soriano V
    J Viral Hepat; 2022 Sep; 29(9):777-784. PubMed ID: 35643914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis D: A Review.
    Negro F; Lok AS
    JAMA; 2023 Dec; 330(24):2376-2387. PubMed ID: 37943548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral hepatitis in persons living with HIV in the post-COVID era.
    Soriano V; Moreno-Torres V; Mendoza C; Corral O; Barreiro P
    AIDS Rev; 2023; 25(1):1-13. PubMed ID: 36952663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma and infections with multiple hepatitis viruses.
    Brunetto MR; Oliveri F; Colombatto P; Bonino F
    Princess Takamatsu Symp; 1995; 25():61-6. PubMed ID: 8875610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral hepatitis associated hepatocellular carcinoma on the African continent, the past, present, and future: a systematic review.
    Dakurah OB; Tamandjou CRT; Zunza M; Preiser W; Maponga TG
    BMC Cancer; 2021 Jun; 21(1):715. PubMed ID: 34144696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients.
    Fernández-Montero JV; Vispo E; Barreiro P; Sierra-Enguita R; de Mendoza C; Labarga P; Soriano V
    Clin Infect Dis; 2014 Jun; 58(11):1549-53. PubMed ID: 24633686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma in cirrhosis: incidence and risk factors.
    Fattovich G; Stroffolini T; Zagni I; Donato F
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S35-50. PubMed ID: 15508101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients.
    Cabibbo G; Celsa C; Calvaruso V; Petta S; Cacciola I; Cannavò MR; Madonia S; Rossi M; Magro B; Rini F; Distefano M; Larocca L; Prestileo T; Malizia G; Bertino G; Benanti F; Licata A; Scalisi I; Mazzola G; Di Rosolini MA; Alaimo G; Averna A; Cartabellotta F; Alessi N; Guastella S; Russello M; Scifo G; Squadrito G; Raimondo G; Trevisani F; Craxì A; Di Marco V; Cammà C;
    J Hepatol; 2019 Aug; 71(2):265-273. PubMed ID: 30959157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
    Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
    J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis viruses and liver transplantation.
    Samuel D; Feray C; Bismuth H
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S335-41. PubMed ID: 9407355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection.
    Wranke A; Heidrich B; Deterding K; Hupa-Breier KL; Kirschner J; Bremer B; Cornberg M; Wedemeyer H
    Hepatol Int; 2023 Dec; 17(6):1359-1367. PubMed ID: 37789170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules.
    Mariño Z; Darnell A; Lens S; Sapena V; Díaz A; Belmonte E; Perelló C; Calleja JL; Varela M; Rodriguez M; Rodriguez de Lope C; Llerena S; Torras X; Gallego A; Sala M; Morillas RM; Minguez B; Llaneras J; Coll S; Carrion JA; Iñarrairaegui M; Sangro B; Vilana R; Sole M; Ayuso C; Ríos J; Forns X; Bruix J; Reig M
    J Hepatol; 2019 May; 70(5):874-884. PubMed ID: 30684506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019.
    Veracruz N; Gish RG; Cheung R; Chitnis AS; Wong RJ
    J Viral Hepat; 2022 May; 29(5):352-365. PubMed ID: 35274406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
    Chu CM
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.